Clinical Significance of IgG Antibody Titer against Helicobacter pylori

Helicobacter

Volumn 14, Issue 3, 2009, Pages 231-236

  Tatemichi, Masayuki ^a,b   Sasazuki, Shizuka ^b   Inoue, Manami ^b   Tsugane, Shoichiro ^b  

^a NATIONAL CANCER CENTER   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Clinical significance; Helicobacter pylori; IgG titer

Indexed keywords

IMMUNOGLOBULIN G; MEMBRANE ANTIGEN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATROPHY; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; STOMACH CANCER; STOMACH MUCOSA;

ADULT; AGED; ANTIBODIES, BACTERIAL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEPSINOGEN A; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 65649097698     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00681.x     Document Type: Article

References (30)

1. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001 49 : 347 53. (Pubitemid 32802568)
2. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 2000 160 : 1192 8. (Pubitemid 30227031)
3. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998 114 : 1169 79. (Pubitemid 28243902)
4. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345 : 784 9.
5. Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 2002 186 : 1138 44. (Pubitemid 35177117)
6. Suzuki G, Cullings H, Fujiwara S, Hattori N, Matsuura S, Hakoda M, Akahoshi M, Kodama K, Tahara E. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. Pylori Cancer Epidemiol Biomarkers Prev 2007 16 : 1224 8. (Pubitemid 46984963)
7. Tatemichi M, Hamada GS, Nishimoto IN, Kowalski LP, Iriya K, Rodrigues JJ, Tsugane S. Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Sci 2003 94 : 64 9. (Pubitemid 36575860)
8. Tatemichi M, Sasazuki S, Inoue M, Tsugane S. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Acta Oncol 2008 47 : 360 5.
9. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007 102 : 1808 25. (Pubitemid 47206706)
10. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008 23 : 351 65.
11. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T, Chey WD, Wong BC. The Japanese guidelines for gastric cancer screening. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Jpn J Clin Oncol 2008 38 : 259 67.
12. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007 56 : 772 81. (Pubitemid 46854190)
13. De Vries AC, Kuipers EJ. Review article. Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007 26 : 25 35. (Pubitemid 350233320)
14. Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Perez-Perez GI, Peek RM Jr. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 2008 88 : 328 36.
15. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004 291 : 187 94. (Pubitemid 38082812)
16. Tatemichi M, Kabuto M, Tsugane S. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori. Jpn J Cancer Res 2001 92 : 243 8. (Pubitemid 32288285)
17. Sasazuki S, Inoue M, Iwasaki M, Otani T, Yamamoto S, Ikeda S, Hanaoka T, Tsugane S. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2006 15 : 1341 7. (Pubitemid 44125292)
18. Miki K. Basic evaluation of pepsinogen EIA kit [in Japanese]. Jpn J Med Pharm Sci 1997 37 : 1013 21.
19. Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, Ozasa K, Kawai K. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 1997 42 : 1383 7. (Pubitemid 27339350)
20. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001 49 : 335 40. (Pubitemid 32802566)
21. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004 109 : 138 43. (Pubitemid 38160674)
22. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005 54 : 764 8. (Pubitemid 40732089)
23. Zagari RM, Pozzato P, Martuzzi C, Fuccio L, Martinelli G, Roda E, Bazzoli F. 13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter 2005 10 : 615 9. (Pubitemid 41668347)
24. Chang YW, Min SK, Kim KJ, Han YS, Lee JH, Dong SH, Kim HJ, Kim BH, Lee JI, Chang R. Delta (13)C-urea breath test value is a useful indicator for Helicobacter pylori eradication in patients with functional dyspepsia. J Gastroenterol Hepatol 2003 18 : 726 31. (Pubitemid 36791713)
25. Lai YC, Yang JC, Huang SH. Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. World J Gastroenterol 2004 10 : 991 4.
26. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 301 310, 2004.
27. Peterson WL. Review article: Helicobacter pylori and gastric adenocarcinoma. Aliment Pharmacol Ther 2002 16 : 40 6. (Pubitemid 41759566)
28. Ang TL, Fock KM, Dhamodaran S, Teo EK, Tan J. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population. J Gastroenterol Hepatol 2005 20 : 1603 9. (Pubitemid 43961118)
29. Yamaoka Y, Graham DY. CagA status and gastric cancer unreliable serological tests produce unreliable data. Gastroenterology 1999 117 : 745. (Pubitemid 29409263)
30. Iwasaki M, Otani T, Yamamoto S, et al. Background characteristics of basic health examination participants: the JPHC Study Baseline Survey. J Epidemiol 2003 13 : 216 25.